Scilex Holding SCLX
NASDAQ SCLX
$5.73 -0.07 (-1.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Amortization of Deferred Charges (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Amortization of Deferred Charges of $1.0 million for Q1 2026, up 151.34% quarter-over-quarter from $409000.0 in Q4 2025.

Scilex Holding (SCLX) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Scilex Holding's Amortization of Deferred Charges history runs 6 years deep, the most recent figure standing at $1.0 million for Q1 2026.

  • In Q1 2026, Amortization of Deferred Charges changed N/A year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.4 million (up 404.21% YoY), while the FY2025 annual figure was $409000.0, up 29.43% from the prior year.
  • Amortization of Deferred Charges for Q1 2026 stood at $1.0 million, up from $409000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $1.9 million in Q1 2022, with the low at $1000.0 in Q2 2023.
  • The 5-year median for Amortization of Deferred Charges is $34000.0 (2022), against an average of $381538.5.
  • The sharpest annual moves came in 2023 and 2024: Amortization of Deferred Charges sank 99.92% in 2023, then jumped 3100.0% in 2024.
  • Scilex Holding's Amortization of Deferred Charges stood at $34000.0 in 2022, then fell by 8.82% to $31000.0 in 2023, then surged by 616.13% to $222000.0 in 2024, then jumped by 84.23% to $409000.0 in 2025, then surged by 151.34% to $1.0 million in 2026.
  • Business Quant data shows SCLX's Amortization of Deferred Charges at $1.0 million in Q1 2026, $409000.0 in Q4 2025, and $222000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Scilex Holding 39.22 Mn -73.57 Mn 3.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.03 Mn
Mar 31, 2026 1.03 Mn
Dec 31, 2025 409,000.00
Dec 31, 2025 409,000.00
Dec 31, 2024 222,000.00
Dec 31, 2024 222,000.00
Sep 30, 2024 31,000.00
Sep 30, 2024 31,000.00
Jun 30, 2024 32,000.00
Jun 30, 2024 32,000.00
Mar 31, 2024 31,000.00
Mar 31, 2024 31,000.00
Dec 31, 2023 31,000.00
Dec 31, 2023 31,000.00
Sep 30, 2023 33,000.00
Sep 30, 2023 33,000.00
Jun 30, 2023 1,000.00
Jun 30, 2023 1,000.00
Dec 31, 2022 34,000.00
Dec 31, 2022 34,000.00